Table 1.
Prognosis for each cytogenetic abnormality according to the risk stratification models for multiple myeloma.
| mSMART [10] | IFM [160] | IMWG [3] | |
|---|---|---|---|
| t(11;14) | Standard risk | ||
| t(4;14) | Intermediate risk | High risk | High risk |
| t(14;16) | High risk | High risk | |
| Del(17p) | High risk | High risk | High risk |
| Del(13q) * | Intermediate risk | ||
| Gain 1q | High risk ** |
* By metaphase cytogenetic. ** According to https://www.msmart.org/mm-treatment-guidelines. mSMART: Stratification for Myeloma and Risk-Adapted Therapy. IFM: Intergroupe Francophone du Myelome. IMWG: International Myeloma Working Group